RecruitingN/Aketamine

Ayahuasca, Esketamine and Premenstrual Symptoms

Sponsored by University of Sao Paulo

NCT ID
NCT07317232
Target Enrollment
20 participants
Start Date
2025-12-20
Est. Completion
2026-07

About This Study

Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine on premenstrual symptoms.

Conditions Studied

Healthy Women Volunteers

Interventions

  • Ayahuasca
  • Esketamine

Eligibility

Sex:FEMALE
Age:18 Years - 65 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* healthy volunteers

Exclusion Criteria:

* psychiatric and other medical comorbidities

Study Locations (1)

Hospital das Clínicas da FMRP-USP
Ribeirão Preto, Brazil

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Ayahuasca, Esketamine and Premenstrual Symptoms | Huxley